Borosil Scientific Limited (BSE: 544184) is a Mumbai, Maharashtra-based company in the Laboratory Equipment and Consumables industry. With a market capitalisation of ₹992 Cr, it ranks #1,591 by market cap among the 6,197 Indian listed companies on FinBizNet. At ₹108.00 (as of 19 Nov 2026), the share price is 40.3% below its 52-week high of ₹180.80 and 11.8% above its 52-week low of ₹96.64. The share price is down 16.0% over one year and down 15.8% over three months.
| Current Price | ₹108.00 |
|---|---|
| Market Cap | ₹992 Cr |
| BSE Code | 544184 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services > Laboratory Equipment and Consumables |
| P/E Ratio | 28.7 |
| Return on Equity | 8.17% |
| Return on Assets | 5.17% |
| 52-Week Range | ₹96.64 – ₹180.80 |
| 1-Year Price Change | -16.0% |
| 3-Month Price Change | -15.8% |
| Beta (1Y) | 0.33 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.borosilscientific.com |
| Revenue | ₹115 Cr |
|---|---|
| Net Profit | ₹5 Cr |
| Net Margin | 4.6% |
| EPS (Basic) | ₹0.60 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Borosil Scientific Limited reported revenue of ₹115 Cr in Q2 FY27, up 7.5% from ₹107 Cr in Q2 FY26 and up 7.7% from ₹107 Cr in Q1 FY27. It posted a net profit of ₹5 Cr for the quarter, against a net profit of ₹3 Cr in Q2 FY26 (up 86.3%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹96 Cr (Q1 FY26) to ₹143 Cr (Q4 FY26). The company reported a net loss in 1 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹115 Cr | ₹5 Cr | 4.6% |
| Q1 FY27 | ₹107 Cr | ₹4 Cr | 4.1% |
| Q4 FY26 | ₹143 Cr | ₹27 Cr | 19.0% |
| Q3 FY26 | ₹121 Cr | ₹9 Cr | 7.2% |
| Q2 FY26 | ₹107 Cr | ₹3 Cr | 2.7% |
| Q1 FY26 | ₹96 Cr | −₹4 Cr | −4.4% |
| Q4 FY25 | ₹129 Cr | ₹9 Cr | 6.7% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 68.27% of Borosil Scientific Limited's shares as of Sept 2026, against 67.81% in Sept 2025 (+0.46 percentage points). Delivery averaged 60.2% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).
Borosil Scientific Limited engages in the manufacture and sale of laboratory glassware. It offers glassware and consumables, including lab glassware, filtration products, and analytical vials; laboratory instrumentation for use in nutrition and environment, life essentials, life sciences, and liquid handling; pharmaceutical primary packaging materials, such as glass ampoules and tubular glass vials; and laboratory process system, comprising mini reactors system; jacketed reactor; parallel reaction; automated reaction; photo and specialty; and utilities and accessories system. The company also provides Industrial Process Equipment and Original Equipment Manufacturing solutions. It serves the pharma, chemical, research, agriculture, food and beverages, and environment industries. The company was formerly known as Klass Pack Limited and changed its name to Borosil Scientific Limited in December 2023. The company was founded in 1962 and is based in Mumbai, India.
1. Scientificware - Laboratory Glass & Equipment and Process System-This segment engages in the provision of laboratory glass and equipment. 2. Glassware-This segment engages in glassware business. 3. Others-NA 4. Unallocated-NA
2. Others-1.2% 3. Glassware-28%
Borosil Scientific Limited is trading at ₹108.00, with a market capitalisation of ₹992 Cr.
Borosil Scientific Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services > Laboratory Equipment and Consumables).
Borosil Scientific Limited has a P/E of 28.7 and a return on equity of 8.17%.
Borosil Scientific Limited is listed on the BSE under the scrip code 544184.
Borosil Scientific Limited's share price is down 16.0% over one year and down 15.8% over three months. Its 52-week range is ₹96.64 to ₹180.80.
In Q2 FY27, Borosil Scientific Limited reported revenue of ₹115 Cr and net profit of ₹5 Cr, with basic EPS of ₹0.6 (consolidated, parsed from the company's exchange filing).
Borosil Scientific Limited reported revenue of ₹115 Cr in Q2 FY27, up 7.5% from ₹107 Cr in Q2 FY26 and up 7.7% from ₹107 Cr in Q1 FY27.
Promoters held 68.27% of Borosil Scientific Limited's shares as of Sept 2026, against 67.81% in Sept 2025 (+0.46 percentage points).
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.